221 related articles for article (PubMed ID: 6369503)
21. Immunohistochemical analysis of thyroglobulin and keratin in benign and malignant thyroid tumours.
Permanetter W; Nathrath WB; Löhrs U
Virchows Arch A Pathol Anat Histopathol; 1982; 398(2):221-8. PubMed ID: 6187120
[TBL] [Abstract][Full Text] [Related]
22. Tumor markers and oncogene expression in thyroid cancer using biochemical and immunohistochemical studies.
Hashimoto T; Matsubara F; Mizukami Y; Miyazaki I; Michigishi T; Yanaihara N
Endocrinol Jpn; 1990 Apr; 37(2):247-54. PubMed ID: 1699752
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous detection of thyroglobulin (Tg), thyroxine (T4), and Triiodothyronine (T3) in nontoxic thyroid tumors by the immunoperoxidase method.
Kawaoi A; Okano T; Nemoto N; Shiina Y; Shikata T
Am J Pathol; 1982 Jul; 108(1):39-49. PubMed ID: 7046455
[TBL] [Abstract][Full Text] [Related]
24. Incidental papillary carcinoma in patients treated surgically for benign thyroid diseases.
Bradly DP; Reddy V; Prinz RA; Gattuso P
Surgery; 2009 Dec; 146(6):1099-104. PubMed ID: 19958937
[TBL] [Abstract][Full Text] [Related]
25. A study of thyroglobulin concentration in the thyroid and serum of patients with different thyroid disorders.
Czarnywojtek A; Krysińska I; Lacka K; Stawny B; Rólski M; Jarzab B; Włoch J; Gembicki M
Arch Immunol Ther Exp (Warsz); 2002; 50(2):143-8. PubMed ID: 12022704
[TBL] [Abstract][Full Text] [Related]
26. Correlation between the loss of thyroglobulin iodination and the expression of thyroid-specific proteins involved in iodine metabolism in thyroid carcinomas.
Gérard AC; Daumerie C; Mestdagh C; Gohy S; De Burbure C; Costagliola S; Miot F; Nollevaux MC; Denef JF; Rahier J; Franc B; De Vijlder JJ; Colin IM; Many MC
J Clin Endocrinol Metab; 2003 Oct; 88(10):4977-83. PubMed ID: 14557483
[TBL] [Abstract][Full Text] [Related]
27. [Content of thyroglobulin polyribosomes in normal and pathological thyroid cells].
Turakulov IaKh; Kadyrooka DA; Atakhanova BA; Leĭtinvl ; Liubimova EV
Biokhimiia; 1979 Feb; 44(2):259-63. PubMed ID: 435565
[TBL] [Abstract][Full Text] [Related]
28. [Low galectin-3 capacity to discriminate thyroid lesions].
De-León-Mazariegos R; Canedo-Patzi M; Pérez-Enríquez B; Candanedo-Gonzalez F; Saqui-Salces M; Gamboa-Domínguez A; Rull-Rodrigo JA
Rev Invest Clin; 2004; 56(5):623-8. PubMed ID: 15776867
[TBL] [Abstract][Full Text] [Related]
29. The quantitative measurement of autoantibodies to thyroglobulin and thyroid peroxidase by automated microparticle based immunoassays in Hashimoto's disease, Graves' disease and a follow-up study on postpartum thyroid disease.
Gilmour J; Brownlee Y; Foster P; Geekie C; Kelly P; Robertson S; Wade E; Braun HB; Staub U; Michel G; Lazarus JH; Parkes AB
Clin Lab; 2000; 46(1-2):57-61. PubMed ID: 10745983
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical demonstration of thyroid peroxidase (TPO) in human thyroid tissues from various thyroid diseases.
Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Nakamura S; Arai Y; Kotani T; Ohtaki S; Matsukawa S
Anticancer Res; 1994; 14(3B):1329-34. PubMed ID: 8067701
[TBL] [Abstract][Full Text] [Related]
31. Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas.
Lin JD; Huang MJ; Hsu BR; Chao TC; Hsueh C; Liu FH; Liou MJ; Weng HF
J Surg Oncol; 2002 May; 80(1):45-51. PubMed ID: 11967907
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical demonstration of epidermal growth factor receptor and ceruloplasmin in thyroid diseases.
Song B
Acta Pathol Jpn; 1991 May; 41(5):336-43. PubMed ID: 1867098
[TBL] [Abstract][Full Text] [Related]
33. Expression of cytokeratin 20 in thyroid carcinomas and peripheral blood detected by reverse transcription polymerase chain reaction.
Weber T; Lacroix J; Weitz J; Amnan K; Magener A; Hölting T; Klar E; Herfarth C; von Knebel Doeberitz M
Br J Cancer; 2000 Jan; 82(1):157-60. PubMed ID: 10638983
[TBL] [Abstract][Full Text] [Related]
34. p27kip1 expression distinguishes papillary hyperplasia in Graves' disease from papillary thyroid carcinoma.
Erickson LA; Yousef OM; Jin L; Lohse CM; Pankratz VS; Lloyd RV
Mod Pathol; 2000 Sep; 13(9):1014-9. PubMed ID: 11007042
[TBL] [Abstract][Full Text] [Related]
35. [Immunohistochemical localization of cytoskeletal proteins and thyroglobulin in thyroid micro cancers].
Yagi S; Yagi Y; Saku T; Hatae M
Gan No Rinsho; 1984 Jun; 30(7):765-71. PubMed ID: 6205176
[TBL] [Abstract][Full Text] [Related]
36. Variable expression of keratins and nearly uniform lack of thyroid transcription factor 1 in thyroid anaplastic carcinoma.
Miettinen M; Franssila KO
Hum Pathol; 2000 Sep; 31(9):1139-45. PubMed ID: 11014583
[TBL] [Abstract][Full Text] [Related]
37. Expression of p63 in papillary thyroid carcinoma and in Hashimoto's thyroiditis: a pathobiologic link?
Unger P; Ewart M; Wang BY; Gan L; Kohtz DS; Burstein DE
Hum Pathol; 2003 Aug; 34(8):764-9. PubMed ID: 14506636
[TBL] [Abstract][Full Text] [Related]
38. Thyroglobulin immunostaining in follicular thyroid carcinoma: relationship to the degree of differentiation and cell type.
Harach HR; Franssila KO
Histopathology; 1988 Jul; 13(1):43-54. PubMed ID: 3061922
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemistry of thyroid carcinoma--an experience with thyroglobulin and calcitonin.
Kavishwar VS; Phatak AM; Rege JD
Indian J Pathol Microbiol; 1998 Apr; 41(2):163-7. PubMed ID: 9670628
[TBL] [Abstract][Full Text] [Related]
40. The anaplastic transformation of differentiated thyroid carcinoma. An ultrastructural study.
Dumitriu L; Stefăneanu L; Taşcă C
Endocrinologie; 1984; 22(2):91-6. PubMed ID: 6740202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
